HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of iatrogenic intravitreal triamcinolone acetonide.

Abstract
Intravitreal corticossteroids have been used for therapeutic purposes in optimum doses and adverse reports have not been described. To best of our knowledge, this entity has never been reported as a problem. We report a case of successful management of iatrogenic intravitreal triamcinolone acetonide for intermediate uveitis. This case study highlights the strategy of appropriate and timely surgical management.
AuthorsAtul Kumar, Gunjan Prakash, Sanjeev Nainiwal
JournalIndian journal of ophthalmology (Indian J Ophthalmol) Vol. 51 Issue 2 Pg. 180-1 (Jun 2003) ISSN: 0301-4738 [Print] India
PMID12831151 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Glucocorticoids
  • Triamcinolone Acetonide
Topics
  • Adult
  • Eye Injuries (etiology, surgery)
  • Glucocorticoids (administration & dosage)
  • Humans
  • Iatrogenic Disease
  • Injections (adverse effects)
  • Male
  • Ophthalmologic Surgical Procedures
  • Triamcinolone Acetonide (administration & dosage)
  • Uveitis, Intermediate (drug therapy)
  • Vitreous Body
  • Wounds, Penetrating (etiology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: